COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: A qualitative study.

L. Storgaard (Aalborg, Denmark), U. Weinreich (Aalborg, Denmark), B. Laursen (Aalborg, Denmark)

Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Session: Reviews and novel insights into pulmonary rehabilitation
Session type: E-poster session
Number: 95
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Storgaard (Aalborg, Denmark), U. Weinreich (Aalborg, Denmark), B. Laursen (Aalborg, Denmark). COPD patients’ experience of long-term domestic oxygen-enriched nasal high flow treatment: A qualitative study.. 95

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A realistic study assessing inhaled treatment compliance in COPD patients
Source: Eur Respir J 2001; 18: Suppl. 33, 25s
Year: 2001

Nasal high flow therapy: The effect on exercise performance in patients with COPD
Source: International Congress 2018 – What’s new in lung function and exercise assessment in COPD?
Year: 2018



Withdrawal of high-dose inhaled corticosteroids in COPD patients with mild or moderate airflow limitation: a feasibility study in primary care.
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

What influences the response to training of inhalation technique in patients with asthma and COPD?
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018

Survival rates among COVID-19 patients treated with high flow nasal oxygen therapy with a do-not-intubate-order: an observational study
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021


Patients with persistent asthma may have poor disease control despite normal lung function: baseline data from a pan-European real-life study
Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009
Year: 2009

Real-life COPD patients compared to large trial populations: An UNLOCK external validity study
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013

Real-world effectiveness of omalizumab in allergic asthma patients with low or high blood eosinophils: A retrospective claims analysis study
Source: International Congress 2018 – New developments in the treatment of asthma
Year: 2018


Comparison of COPD patients with high and low symptoms from a real-world US survey
Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases
Year: 2015


Feasibility of typical COPD study patients related to a larger real life patient population
Source: Eur Respir J 2002; 20: Suppl. 38, 256s
Year: 2002

The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma
Source: International Congress 2017 – Bronchial asthma management
Year: 2017


High flow nasal cannula use on respiratory inpatients: Identifying patient groups and outcomes to guide optimal future use.
Source: International Congress 2018 – New methods for diagnosing and treating lung diseases
Year: 2018




Domiciliary treatment with noninvasive ventilation in patients with severe COPD: a 4 year retrospective study
Source: Eur Respir J 2006; 28: Suppl. 50, 187s
Year: 2006

Three practical case studies on COPD using a remote voting system: 3. At home: Long-term NIV for stable hypercapnic COPD
Source: Annual Congress 2013 –Management of COPD with NIV
Year: 2013

Feasibility of typical asthma study patients related to a larger real life patient population
Source: Eur Respir J 2002; 20: Suppl. 38, 409s
Year: 2002

Modeling exacerbation using ozone exposure in COPD patients: CO3PD pilot study
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018



Effect of nasal high flow heated oxygen in chronic airway disease on quality of life and hospital admissions
Source: International Congress 2016 – Latest insights into the management of chronic respiratory diseases
Year: 2016

Change of inhalation device: impact on asthma control and compliance in general practice. SYSTER survey
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of pulmonary diseases II
Year: 2008


Importance of inhaler device use status in the control of asthma and COPD: a real life study.
Source: International Congress 2018 – Pulmonary drug delivery: inhaler use, devices and technologies
Year: 2018


6MWT improvement after pulmonary rehabilitation (PR) is inversely associated with degree of airflow obstruction in COPD patients. A retrospective study
Source: Annual Congress 2013 –The latest insights in exercise testing and physical inactivity
Year: 2013